{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:02:31Z","timestamp":1779688951369,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82470565"],"award-info":[{"award-number":["No. 82470565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yong Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University","award":["JSPH-MC-2023-18"],"award-info":[{"award-number":["JSPH-MC-2023-18"]}]},{"name":"Chongqing Natural Science Foundation General Project .","award":["CSTB2024NSCQ-MSX1197"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1197"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10620-025-09589-5","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T10:50:09Z","timestamp":1764413409000},"page":"1913-1925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of the Esophageal Microbiota in Patients with Achalasia"],"prefix":"10.1007","volume":"71","author":[{"given":"Yuxia","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"9589_CR1","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1001\/jama.2015.2996","volume":"313","author":"JE Pandolfino","year":"2015","unstructured":"Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA 2015;313:1841\u20131852. https:\/\/doi.org\/10.1001\/jama.2015.2996.","journal-title":"JAMA"},{"key":"9589_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41572-022-00356-8","volume":"8","author":"E Savarino","year":"2022","unstructured":"Savarino E, Bhatia S. Achalasia. 2022;8:28. https:\/\/doi.org\/10.1038\/s41572-022-00356-8.","journal-title":"Achalasia."},{"key":"9589_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00535-018-01544-8","volume":"54","author":"H Sato","year":"2019","unstructured":"Sato H et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J Gastroenterol 2019;54:621\u2013627. https:\/\/doi.org\/10.1007\/s00535-018-01544-8.","journal-title":"J Gastroenterol"},{"key":"9589_CR4","doi-asserted-by":"publisher","unstructured":"van Hoeij, F.B., et al., Incidence and costs of achalasia in The Netherlands. Neurogastroenterol Motil, 2018. 30.https:\/\/doi.org\/10.1111\/nmo.13195.","DOI":"10.1111\/nmo.13195"},{"key":"9589_CR5","doi-asserted-by":"publisher","unstructured":"Harvey, P.R., et al., Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. 2019. 68: p. 790\u2013795.https:\/\/doi.org\/10.1136\/gutjnl-2018-316089.","DOI":"10.1136\/gutjnl-2018-316089"},{"key":"9589_CR6","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1111\/j.1365-2982.2010.01511.x","volume":"22","author":"DC Sadowski","year":"2010","unstructured":"Sadowski DC et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010;22:e256\u2013e261. https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01511.x.","journal-title":"A population-based study. Neurogastroenterol Motil"},{"key":"9589_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MCG.0000000000000780","volume":"51","author":"A Pressman","year":"2017","unstructured":"Pressman A, Behar J. Etiology and Pathogenesis of Idiopathic Achalasia. J Clin Gastroenterol 2017;51:195\u2013202. https:\/\/doi.org\/10.1097\/MCG.0000000000000780.","journal-title":"J Clin Gastroenterol"},{"key":"9589_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1442-2050.2011.01249.x","volume":"25","author":"JD Booy","year":"2012","unstructured":"Booy JD et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus 2012;25:209\u2013213. https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01249.x.","journal-title":"Dis Esophagus"},{"key":"9589_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.14309\/ajg.0000000000001006","volume":"116","author":"D King","year":"2021","unstructured":"King D et al. Achalasia Is Associated With Atopy in Patients Younger Than 40 Years of Age. Am J Gastroenterol 2021;116:416\u2013419. https:\/\/doi.org\/10.14309\/ajg.0000000000001006.","journal-title":"Am J Gastroenterol"},{"key":"9589_CR10","doi-asserted-by":"publisher","unstructured":"Romero-Hern\u00e1ndez, F. and J. Furuzawa-Carballeda, Autoimmune comorbidity in achalasia patients. 2018. 33: p. 203-208.https:\/\/doi.org\/10.1111\/jgh.13839","DOI":"10.1111\/jgh.13839"},{"key":"9589_CR11","doi-asserted-by":"publisher","unstructured":"Sara, C., et al., Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases. Dis Esophagus, 2021. 34.https:\/\/doi.org\/10.1093\/dote\/doaa072.","DOI":"10.1093\/dote\/doaa072"},{"key":"9589_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/meg.0000000000000602","volume":"28","author":"J Becker","year":"2016","unstructured":"Becker J et al. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia. Eur J Gastroenterol Hepatol 2016;28:689\u2013695. https:\/\/doi.org\/10.1097\/meg.0000000000000602.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9589_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ejhg.2015.262","volume":"24","author":"J Becker","year":"2016","unstructured":"Becker J et al. The HLA-DQ\u03b21 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur J Hum Genet 2016;24:1228\u20131231. https:\/\/doi.org\/10.1038\/ejhg.2015.262.","journal-title":"Eur J Hum Genet"},{"key":"9589_CR14","doi-asserted-by":"publisher","unstructured":"Furuzawa-Carballeda, J., et al., An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia. 2018. 13(8): e0201676.https:\/\/doi.org\/10.1371\/journal.pone.0201676.","DOI":"10.1371\/journal.pone.0201676"},{"key":"9589_CR15","doi-asserted-by":"publisher","unstructured":"N\u00f6then, M.M., et al., United European Gastroenterol J. https:\/\/doi.org\/10.1177\/2050640618804717.","DOI":"10.1177\/2050640618804717"},{"key":"9589_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang L et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009;137:588\u2013597. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.046.","journal-title":"Gastroenterology"},{"key":"9589_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes 2020;12:1\u201324. https:\/\/doi.org\/10.1080\/19490976.2020.1788899.","journal-title":"Gut Microbes"},{"key":"9589_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/518578","volume":"45","author":"S Macfarlane","year":"2007","unstructured":"Macfarlane S et al. Microbial colonization of the upper gastrointestinal tract in patients with Barrett\u2019s esophagus. Clin Infect Dis 2007;45:29\u201338. https:\/\/doi.org\/10.1086\/518578.","journal-title":"Clin Infect Dis"},{"key":"9589_CR19","doi-asserted-by":"publisher","unstructured":"Power, D.J., V. Ho, and J. Zhou, Association between Oral Microbiome and Gastroesophageal Reflux Severity. J Clin Med, 2024. 13.https:\/\/doi.org\/10.3390\/jcm13154479.","DOI":"10.3390\/jcm13154479"},{"key":"9589_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02759-22","volume":"11","author":"N Ding","year":"2023","unstructured":"Ding N et al. Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production. Microbiol Spectr 2023;11:e0275922. https:\/\/doi.org\/10.1128\/spectrum.02759-22.","journal-title":"Microbiol Spectr"},{"key":"9589_CR21","doi-asserted-by":"publisher","unstructured":"Yadlapati, R., P.J. Kahrilas, and M.R. Fox, Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(\u00a9). 2021. 33: p. e14058.https:\/\/doi.org\/10.1111\/nmo.14058.","DOI":"10.1111\/nmo.14058"},{"key":"9589_CR22","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","journal-title":"Genome Biol"},{"key":"9589_CR23","doi-asserted-by":"publisher","first-page":"1261359","DOI":"10.1126\/science.1261359","volume":"348","author":"S Sunagawa","year":"2015","unstructured":"Sunagawa S et al. Ocean plankton. Structure and function of the global ocean microbiome. Science 2015;348:1261359. https:\/\/doi.org\/10.1126\/science.1261359.","journal-title":"Science"},{"key":"9589_CR24","doi-asserted-by":"publisher","unstructured":"Douglas, G.M. and V.J. Maffei, PICRUSt2 for prediction of metagenome functions. 2020. 38: p. 685\u2013688.https:\/\/doi.org\/10.1038\/s41587-020-0548-6.","DOI":"10.1038\/s41587-020-0548-6"},{"key":"9589_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01237-z","author":"SS Jiang","year":"2025","unstructured":"Jiang SS, Chen YX, Fang JY. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications. Nat Rev Microbiol. 2025. https:\/\/doi.org\/10.1038\/s41579-025-01237-z.","journal-title":"Nat Rev Microbiol"},{"key":"9589_CR26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T et al. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion. Cancer Res 2025;85:1819\u20131841. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2580.","journal-title":"Cancer Res"},{"key":"9589_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/07357907.2024.2359980","volume":"42","author":"T Tahara","year":"2024","unstructured":"Tahara T et al. Fusobacterium Detected in Barrett\u2019s Esophagus and Esophageal Adenocarcinoma Tissues. Cancer Invest 2024;42:469\u2013477. https:\/\/doi.org\/10.1080\/07357907.2024.2359980.","journal-title":"Cancer Invest"},{"key":"9589_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","volume":"17","author":"CA Brennan","year":"2019","unstructured":"Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol 2019;17:156\u2013166. https:\/\/doi.org\/10.1038\/s41579-018-0129-6.","journal-title":"Nat Rev Microbiol"},{"key":"9589_CR29","doi-asserted-by":"publisher","first-page":"1270974","DOI":"10.3389\/fmicb.2023.1270974","volume":"14","author":"C Carbonne","year":"2023","unstructured":"Carbonne C et al. Ligilactobacillus salivarius CNCM I-4866, a potential probiotic candidate, shows anti-inflammatory properties in vitro and in vivo. Front Microbiol 2023;14:1270974. https:\/\/doi.org\/10.3389\/fmicb.2023.1270974.","journal-title":"Front Microbiol"},{"key":"9589_CR30","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.1039\/d3fo03867j","volume":"14","author":"S Yan","year":"2023","unstructured":"Yan S et al. Ligilactobacillus salivarius CCFM 1266 modulates gut microbiota and GPR109a-mediated immune suppression to attenuate immune checkpoint blockade-induced colitis. Food Funct 2023;14:10549\u201310563. https:\/\/doi.org\/10.1039\/d3fo03867j.","journal-title":"Food Funct"},{"key":"9589_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934695","volume":"13","author":"VF Rodrigues","year":"2022","unstructured":"Rodrigues VF et al. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol 2022;13:934695. https:\/\/doi.org\/10.3389\/fimmu.2022.934695.","journal-title":"Front Immunol"},{"key":"9589_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12885-016-2093-8","volume":"16","author":"AH Zaidi","year":"2016","unstructured":"Zaidi AH et al. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer 2016;16:52. https:\/\/doi.org\/10.1186\/s12885-016-2093-8.","journal-title":"BMC Cancer"},{"key":"9589_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014;156:317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"key":"9589_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C et al. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 2018;136:345\u2013361. https:\/\/doi.org\/10.1007\/s00401-018-1856-5.","journal-title":"Acta Neuropathol"},{"key":"9589_CR35","doi-asserted-by":"publisher","unstructured":"Yeh, C.C., et al., Characteristics of the esophageal microbiome in patients with achalasia and its changes before and after peroral endoscopic myotomy: A pilot study. 2023. 38: p. 1307-1315.https:\/\/doi.org\/10.1111\/jgh.16192.","DOI":"10.1111\/jgh.16192"},{"key":"9589_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s1091-255x(02)00028-8","volume":"6","author":"D Pajecki","year":"2002","unstructured":"Pajecki D et al. Megaesophagus microbiota: a qualitative and quantitative analysis. J Gastrointest Surg 2002;6:723\u2013729. https:\/\/doi.org\/10.1016\/s1091-255x(02)00028-8.","journal-title":"J Gastrointest Surg"},{"key":"9589_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5056\/jnm19240","volume":"26","author":"CH Park","year":"2020","unstructured":"Park CH, Lee SK. Exploring Esophageal Microbiomes in Esophageal Diseases: A Systematic Review. J Neurogastroenterol Motil 2020;26:171\u2013179. https:\/\/doi.org\/10.5056\/jnm19240.","journal-title":"J Neurogastroenterol Motil"},{"key":"9589_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.981343","volume":"3","author":"H Ozuna","year":"2022","unstructured":"Ozuna H et al. Aggregatibacter actinomycetemcomitans and Filifactor alocis: Two exotoxin-producing oral pathogens. Front Oral Health 2022;3:981343. https:\/\/doi.org\/10.3389\/froh.2022.981343.","journal-title":"Front Oral Health"},{"key":"9589_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127470","volume":"276","author":"ZH Geng","year":"2023","unstructured":"Geng ZH et al. The role of type II esophageal microbiota in achalasia: Activation of macrophages and degeneration of myenteric neurons. Microbiol Res 2023;276:127470. https:\/\/doi.org\/10.1016\/j.micres.2023.127470.","journal-title":"Microbiol Res"},{"key":"9589_CR40","doi-asserted-by":"publisher","first-page":"2489070","DOI":"10.1080\/19490976.2025.2489070","volume":"17","author":"Z Xiang","year":"2025","unstructured":"Xiang Z et al. Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation. Gut Microbes 2025;17:2489070. https:\/\/doi.org\/10.1080\/19490976.2025.2489070.","journal-title":"Gut Microbes"},{"key":"9589_CR41","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1128\/IAI.68.5.2907-2915.2000","volume":"68","author":"S Krisanaprakornkit","year":"2000","unstructured":"Krisanaprakornkit S et al. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000;68:2907\u20132915. https:\/\/doi.org\/10.1128\/IAI.68.5.2907-2915.2000.","journal-title":"Infect Immun"},{"key":"9589_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191209","volume":"13","author":"SH Ahn","year":"2018","unstructured":"Ahn SH et al. Correction: Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection. PLoS One 2018;13:e0191209. https:\/\/doi.org\/10.1371\/journal.pone.0191209.","journal-title":"PLoS One"},{"key":"9589_CR43","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1128\/IAI.01311-15","volume":"84","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S et al. FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1\/2 (TLR-1\/2) and TLR-2\/6. Infect Immun 2016;84:1446\u20131456. https:\/\/doi.org\/10.1128\/IAI.01311-15.","journal-title":"Infect Immun"},{"key":"9589_CR44","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/IAI.01226-13","volume":"82","author":"SR Park","year":"2014","unstructured":"Park SR et al. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages. Infect Immun 2014;82:1914\u20131920. https:\/\/doi.org\/10.1128\/IAI.01226-13.","journal-title":"Infect Immun"},{"key":"9589_CR45","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1128\/jb.00542-10","volume":"192","author":"FE Dewhirst","year":"2010","unstructured":"Dewhirst FE et al. The human oral microbiome. J Bacteriol 2010;192:5002\u20135017. https:\/\/doi.org\/10.1128\/jb.00542-10.","journal-title":"J Bacteriol"},{"key":"9589_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/dnares\/dsw002","volume":"23","author":"S Nishijima","year":"2016","unstructured":"Nishijima S et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res 2016;23:125\u2013133. https:\/\/doi.org\/10.1093\/dnares\/dsw002.","journal-title":"DNA Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09589-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09589-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09589-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:06:29Z","timestamp":1779685589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09589-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["9589"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09589-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7849916\/v1","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Nanjing Medical University and was then registered in the Chinese Clinical Trial Registry\u2014World Health Organization International Clinical Trial Registry Platform (\n                      \n                      No.ChiCTR2400082908 date:2024\u201304-10). Informed consent was obtained from each subject enrolled. All experiments were performed in accordance with relevant guidelines and regulation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}